Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

  • This share is currently suspended. It was suspended at a price of 37.50
  • There is currently no data for CAT

Rule 8.3- (CAT)

5 Jun 2006 13:10

Bear Stearns Intl. Trading Ltd05 June 2006 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing (Note 1) Bear Stearns International Trading LimitedCompany dealt in Cambridge Antibody Technology PlcClass of relevant security to which the Ordinarydealings being disclosed relate (Note 2)Date of dealing 2/6/2006 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 1,964,554 3.693% 1,038,103 1.951%(2) Derivatives (other than options)(3) Options and agreements topurchase/sellTotal 1,964,554 3.693% 1,038,103 1.951% (b) Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%)(1) Relevant securities(2) Derivatives (other than options)(3) Options and agreements to purchase/sellTotal (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/Sale Number of Currency Price per unit (Note Securities 5)B 25000 GBP 1306 (b) Derivatives transactions (other than options) Product Long/short (Note Number of Currency Price pername, 6) securities unite.g. CFD (Note 7) (Note 5) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Optionname,e.g. selling, securities to price American, date money paid/call purchasing, which the European receivedoption varying etc. option etc. per unit relates (Note (Note 5) 7) (ii) Exercising Product name, e.g. Number of securities Exercise price per unit (Note 5)call option (d) Other dealings (including new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. ........................................................................ Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 5/6/2006 Contact name James Step Telephone number 020 7516 5310 If a connected EFM, name of offeree/offeror with N/Awhich connectedIf a connected EFM, state nature of connection N/A(Note 10) This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Aug 20183:51 pmRNSDirector/PDMR Shareholding
29th Aug 201812:08 pmRNSDirector/PDMR Shareholding
20th Aug 20187:00 amRNSNet Asset Value(s)
17th Aug 20187:00 amRNSHalf-year Report
16th Jul 20182:44 pmRNSNet Asset Value(s)
10th Jul 20182:57 pmRNSHolding(s) in Company
21st Jun 20185:09 pmRNSReplacement Share Interest Acquisition CEO Inv Mgr
21st Jun 20183:10 pmRNSShare Interests Acquisition by CEO of Inv Manager
21st Jun 201811:35 amRNSShare Interests Acquisition by CEO of Inv Manager
20th Jun 20181:42 pmRNSDirector/PDMR Shareholding
18th Jun 20187:00 amRNSNet Asset Value(s)
18th Jun 20187:00 amRNSShare Interests Acquisition by CEO of Inv Manager
1st Jun 20184:07 pmRNSPublication of Suppl.Prospcts
17th May 201810:00 amRNSShare Interests Acquisition by CEO of Inv Manager
16th May 20187:00 amRNSNet Asset Value(s)
15th May 201812:35 pmRNSDirector/PDMR Shareholding
14th May 201812:51 pmRNSDirector/PDMR Shareholding
14th May 201812:02 pmRNSDirector/PDMR Shareholding
8th May 20187:00 amRNSPortfolio Update
19th Apr 20181:58 pmRNSResult of AGM
19th Apr 20187:00 amRNSNet Asset Value(s)
29th Mar 20187:00 amRNSNet Asset Value(s)
21st Mar 20183:52 pmRNSHolding(s) in Company
20th Mar 201812:45 pmRNSPublication of Suppl.Prospcts
12th Mar 20187:00 amRNSFinal Results
5th Mar 20187:00 amRNSNet Asset Value(s)
15th Feb 20184:00 pmRNSPublication of Suppl.Prospcts
14th Feb 20183:26 pmRNSHolding(s) in Company
12th Feb 20181:34 pmRNSHolding(s) in Company
9th Feb 201810:46 amRNSHolding(s) in Company
2nd Feb 20187:00 amRNSPortfolio Update
1st Feb 201812:00 pmRNSPublication of Suppl.Prospcts
31st Jan 20184:20 pmRNSDividend Declaration
19th Jan 20187:00 amRNSNet Asset Value(s) and Portfolio Update
2nd Jan 20187:00 amRNSPRIIPs Key Information Documents
12th Dec 20177:00 amRNSNet Asset Value(s)
8th Dec 20177:00 amRNSIssue of Equity - correction
7th Dec 20175:44 pmRNSHolding(s) in Company
7th Dec 20177:00 amRNSIssue of Equity
5th Dec 20179:52 amRNSHolding(s) in Company
29th Nov 20174:40 pmRNSIssue of Equity - Correction
28th Nov 20173:50 pmRNSIssue of Equity
15th Nov 201711:02 amRNSPublication of Suppl.Prospcts
13th Nov 20177:00 amRNSNet Asset Value(s)
8th Nov 20177:00 amRNSPublication of a Prospectus
7th Nov 20171:17 pmRNSResult of Special General Meeting
6th Nov 20174:45 pmRNSHolding(s) in Company
17th Oct 20171:04 pmRNSHolding(s) in Company
17th Oct 20177:00 amRNSNet Asset Value
13th Oct 201711:36 amRNSNotice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.